Skip to main content
Zura Bio Ltd logo

Zura Bio Ltd — Investor Relations & Filings

Ticker · ZURA ISIN · KYG507521071 LEI · 549300LQXD6M2MIQFN24 US Manufacturing
Open in API
Filings indexed 394 across all filing types
Latest filing 2023-06-15 Major Shareholding Noti…
Country KY Cayman Islands
Listing US ZURA

About Zura Bio Ltd

https://zurabio.com/

Zura Bio Ltd. is a multi-asset, clinical-stage biotechnology company focused on developing novel medicines for severe autoimmune and inflammatory disorders. The company's strategy centers on dual-pathway biology, aiming to create transformative solutions for patients whose needs are not adequately met by single-pathway medicines. Its development portfolio includes the therapeutic candidates tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880). Zura Bio's mission is to enhance patient well-being by developing innovative dual-pathway antibody therapies that demonstrate efficacy, safety, and dosing convenience for challenging immunological conditions.

Recent filings

Filing Released Lang Actions
SC 13G
Major Shareholding Notification
2023-06-15 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-06-15 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Zura Bio Limited. It primarily announces the use of an Investor Presentation dated June 2023, which is attached as Exhibit 99.1. The text explicitly states that the presentation is being used for investor and analyst communications during the fiscal year. There are no financial statements or detailed financial data included in the text itself, only a reference to the presentation. The document is about disclosure of an investor presentation rather than the presentation content itself. According to the rules, such a filing that announces or attaches an investor presentation should be classified as Investor Presentation (IP). The document length is about 5095 characters, which is sufficient to contain substantive content, but the content is clearly an 8-K filing announcing and furnishing an investor presentation, not a full financial report or earnings release. Therefore, the best classification is Investor Presentation (IP) with high confidence.
2023-06-14 English
FORM-S-1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering. It includes detailed information about the securities being registered, selling securityholders, business combination agreements, and other related disclosures. The document is a preliminary prospectus related to a securities offering, not a financial report, earnings release, or management discussion. It is a regulatory filing related to capital raising and securities registration under the Securities Act of 1933. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a report publication announcement but a full registration statement/prospectus.
2023-06-13 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on unregistered sales of equity securities (a private placement), subscription agreements, closings of securities sales, and related disclosures. It also includes a press release and references to exhibits such as warrant forms and subscription agreements. There are no comprehensive financial statements or detailed financial performance data typical of annual or quarterly reports. The document is primarily an announcement of financing activity and related disclosures, not a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (6639 characters) supports it being a substantive filing rather than a brief announcement. Hence, the classification is CAP with high confidence.
2023-06-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2023-06-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.